NCT01264679View on ClinicalTrials.gov

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 27, 2011

Primary Completion Date

April 24, 2015

Study Completion Date

April 24, 2015

Conditions
Iron Deficiency Anemia
Interventions
DRUG

Ferumoxytol

IV Ferumoxytol

Trial Locations (1)

02451

AMAG Pharmaceuticals, Inc., Waltham

Sponsors
All Listed Sponsors
lead

AMAG Pharmaceuticals, Inc.

INDUSTRY